Surgeons to Observe and Discuss Live Eye Surgery Friday Night in Boston
Bausch & Lomb Premium Cataract Intraocular Lenses to Be Featured

FOR RELEASE WEDNESDAY, APRIL 7, 2010

BOSTON- Over 1,000 cataract surgeons will attend a live surgery and symposium at a Boston hotel Friday night. They will observe two surgical procedures conducted by Dr. Jeffrey Whitman broadcast live from Key Whitman Eye Center in Dallas, Texas. Dr. Whitman will implant the Crystalens AO, the only FDA approved accommodating intraocular lens (IOL) in one patient and the Akreos™ MICS lens in another patient. Surgeons will be able to observe and discuss the surgery during the Friday evening event.

"I'm honored to be sharing this experience with the surgeons who will be watching live in Boston. It promises to be an excellent experience for all of us. This opportunity to observe and discuss a surgery benefits both surgeons and our cataract and presbyopic patients," said Dr. Jeffrey Whitman.

The live surgery and symposium - entitled "Celebrating Innovations in Premium and Micro-Incision Advanced Optics Live Surgery and Symposium” - will be held at the Boston Sheraton Hotel in Boston on Friday night, April 9. It is being sponsored by Bausch + Lomb. The American Society of Cataract and Refractive Surgery’s (ASCRS) Annual Meeting is being held at the Boston Convention & Exhibition Center and has attracted thousands of surgeons to the Boston area.

"Bausch + Lomb is pleased to sponsor this live surgery and symposium event. There are many premium solutions available to cataract surgeons today and this type of symposium provides an excellent opportunity for surgeons to share new surgical techniques and ideas with each other which benefit all of us in the industry, particularly the patient," said Tom Frinzi, vice-president of sales for Bausch + Lomb Surgical."

There are 3 million cataract surgeries every year. A cataract is a clouding on the normally clear lens in your eye. When it forms, the natural lens in the patient's eye is replaced by an intraocular lens. Advertising research indicated that only a small fraction of people realized that not all intraocular lenses are the same. The research also indicated that a number of patients are willing to pay a little extra money in order to get the best vision.

Crystalens® AO is the only FDA approved accommodating intraocular lens. Unlike the standard cataract replacement lenses, Crystalens AO not only eliminates the patient's cataract but also gives the patient full range of vision so that the patient can see near, far and everything in between. Many Crystalens patients hardly ever need their glasses or contacts again.
The Akreos MICS lens - also made by Bausch + Lomb - is the final step on the path to sub 2 mm microincision cataract surgery. The lens is inserted through a 1.8mm incision and provides exceptional vision quality and contrast sensitivity with an aberration-free design.

In both surgeries, the patient's natural lens will be removed by the Stellaris™ Vision Enhancement System which creates a removal incision of only 1.8 mm, which is the smallest incision currently available to surgeons and their patients. The smaller incision complements the surgical technique and helps develop positive patient results.
For more information about the Crystalens HD and the Akreos MICS lens and the Stellaris, please visit www.bauschsurgical.com

###

About Bausch + Lomb
Bausch + Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.

Crystalens is a registered trademark of Bausch & Lomb.
Akreos  is a registered trademark of Bausch & Lomb.
Stellaris  is a registered trademark of Bausch & Lomb.